NEXTCURE, INC Retained Earnings
NEXTCURE, INC (NXTC) had Retained Earnings of -$460.67 million as of 2026-06-30, per its S-4 filed 2026-08-18.
Financial Statements › Balance Sheet › Equity › Equity, Attributable to Parent
us-gaap:RetainedEarningsAccumulatedDeficit · last filed 2026-08-18
- 2026-06-30: Retained Earnings (Accumulated Deficit) -$460.67M.
- 2026-03-31: Retained Earnings (Accumulated Deficit) -$445.78M.
- 2025-12-31: Retained Earnings (Accumulated Deficit) -$435.98M.
- 2025-09-30: Retained Earnings (Accumulated Deficit) -$426.54M.
| Period end | Retained Earnings (Accumulated Deficit) |
|---|---|
| 2026-06-30 | -$460.67M S-4 · filed 2026-08-18 |
| 2026-03-31 | -$445.78M 10-Q · filed 2026-05-07 |
| 2025-12-31 | -$435.98M S-4 · filed 2026-08-18 |
| 2025-09-30 | -$426.54M 10-Q · filed 2025-11-05 |
| 2025-06-30 | -$417.92M 10-Q · filed 2025-08-07 |
| 2025-03-31 | -$391.11M 10-Q · filed 2025-05-01 |
| 2024-12-31 | -$380.14M S-4 · filed 2026-08-18 |
| 2024-09-30 | -$368.53M 10-Q · filed 2024-11-07 |
| 2024-06-30 | -$356.99M 10-Q · filed 2024-08-01 |
| 2024-03-31 | -$341.59M 10-Q · filed 2024-05-02 |
| 2023-12-31 | -$324.48M 10-K · filed 2025-03-06 |
| 2023-09-30 | -$310.01M 10-Q · filed 2023-11-02 |
| 2023-06-30 | -$295.71M 10-Q · filed 2023-08-03 |
| 2023-03-31 | -$277.86M 10-Q · filed 2023-05-04 |
| 2022-12-31 | -$261.76M 10-K · filed 2024-03-21 |
| 2022-09-30 | -$244.46M 10-Q · filed 2022-11-03 |
| 2022-06-30 | -$225.55M 10-Q · filed 2022-08-04 |
| 2022-03-31 | -$207.63M 10-Q · filed 2022-05-05 |
| 2021-12-31 | -$187.03M 10-K · filed 2023-03-02 |
| 2021-09-30 | -$170.09M 10-Q · filed 2021-11-04 |
| 2021-06-30 | -$152.16M 10-Q · filed 2021-08-05 |
| 2021-03-31 | -$134.17M 10-Q · filed 2021-05-06 |
| 2020-12-31 | -$117.64M 10-K · filed 2022-03-03 |
| 2020-09-30 | -$102.18M 10-Q · filed 2020-11-05 |
| 2020-06-30 | -$85.81M 10-Q · filed 2020-08-06 |
| 2020-03-31 | -$71.30M 10-Q · filed 2020-05-07 |
| 2019-12-31 | -$81.03M 10-K · filed 2021-03-04 |
| 2019-09-30 | -$70.11M 10-Q · filed 2019-11-12 |
| 2019-06-30 | -$61.67M 10-Q · filed 2019-08-12 |
| 2019-03-31 | -$53.45M 10-Q · filed 2019-06-10 |
| 2018-12-31 | -$47.30M 10-K · filed 2020-03-12 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| TherapeuticsMD, Inc. (TXMD) | United States | $0.024B | -117.87 |
| AYTU BIOPHARMA, INC (AYTU) | United States | $0.025B | -1.62 |
| ARTELO BIOSCIENCES, INC. (ARTL) | United States | $0.023B | |
| Cocrystal Pharma, Inc. (COCP) | United States | $0.022B | |
| ATOSSA THERAPEUTICS, INC. (ATOS) | United States | $0.021B | -0.52 |
| KYNTRA BIO, INC. (KYNB) | United States | $0.028B | 0.17 |
| Transcode Therapeutics, Inc. (RNAZ) | United States | $0.029B | -0.12 |
| Hepion Pharmaceuticals, Inc. (HEPA) | United States | $0.029B | -0.62 |
| Neuphoria Therapeutics Inc. (NEUP) | United States | $0.020B | -1.77 |
| Marker Therapeutics, Inc. (MRKR) | United States | $0.020B | -2.86 |